Furthermore, chemotherapy upregulated cancer-specific variants of POSTN and application of a blocking antibody specifically targeting those variants overcame chemoresistance as well as halted disease progression in the absence of toxic effects [318]. This evidence concerns the gene POSTN and cancer.